Pulmonary Hypoplasia Program News

The Philadelphia County Medical Society (PCMS) has awarded CHOP surgeon Holly L. Hedrick, MD the 2023 Strittmatter Award, its most prestigious scientific honor.

A range of different noninvasive mechanical ventilation supports helped this patient with pulmonary hypoplasia avoid tracheostomy.

Learn how CHOP’s dedicated CDH team translates research findings into care advances that improve the lives of children with this condition.

CHOP's specialized Pulmonary Hypoplasia Program provides ongoing developmental and medical assessments from infancy through adolescence, with the goal of looking beyond short-term surgical survival and providing long-term clinical care to improve quality of life.

Early recognition, treatment and management of CDH-related pulmonary hypertension is critical. Our team takes an early and aggressive approach to treatment, and our protocols have been extremely successful.

CHOP collaboration with Nestlé Health Science elevates an idea that is a win for families.

We evaluate hundreds of children from around the world and offer complete care — from evaluation through long-term follow-up — for severe spine and rib cage abnormalities.

The Pulmonary Hypoplasia Program at The Children’s Hospital of Philadelphia is committed to tracking outcomes of children with pulmonary hypoplasia in an effort to improve understanding and care. A recent review of neurodevelopmental outcomes at 5 years of age found that CDH survivors are at increased risk for developing emotionally reactive and pervasive developmental problems.

Neonates with congenital diaphragmatic hernia (CDH) often require intensive treatment after birth and have prolonged hospitalizations, and may suffer a variety of complications after discharge. Comprehensive interdisciplinary follow-up care is critical for long-term well being.